Not Signed In -
Celecoxib |
Celebrex |
Celecoxib Systematic (IUPAC) name 4-[5-(4-methylphenyl)-3-(trifluoromethyl) pyrazol-1-yl]benzenesulfonamide Identifiers CAS number 169590-42-5 ATC code L01XX33 M01AH01 PubChem 2662 DrugBank APRD00373 Chemical data Formula C17H14N3F3O2S Mol. weight 381.373 g/mol Pharmacokinetic data Bioavailability ? Protein binding 97% (mainly to albumin) Metabolism Hepatic (mainly CYP2C9) Half life ~11 hours Excretion Renal 27%, faecal 57% Therapeutic con ...
Wikipedia - [full article]
Celecoxib Clinical Trials
- Study Of Continuous Use Of Celecoxib Vs. Intermittent Use
ClinicalTrials.gov Identifier: NCT00139776 - Active, not recruiting
Osteoarthritis
- Celecoxib in Preventing Skin Cancer in Patients With Actinic Keratoses
ClinicalTrials.gov Identifier: NCT00027976 - Active, not recruiting
actinic keratosis
- Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
ClinicalTrials.gov Identifier: NCT00052611 - Active, not recruiting
Head and Neck Cancer
- Cisptain, CPT-11 and Celecoxib with Radiation Therapy and Surgery for Operable Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00137852 - Active, not recruiting
Resectable Esophageal Cancer
- Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery
ClinicalTrials.gov Identifier: NCT00474773 - Recruiting
Pain Management; Function; Minimally Invasive Total Knee Arthroplasty; Celecoxib
- Use of Celecoxib in Patients with Intraductal Papillary Mucinous Neoplasms (IPMNs)
ClinicalTrials.gov Identifier: NCT00198081 - Recruiting
Pancreas Neoplasms
- Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
ClinicalTrials.gov Identifier: NCT00084370 - Active, not recruiting
ovarian epithelial cancer
- Celecoxib in Treating Patients With Bladder Cancer
ClinicalTrials.gov Identifier: NCT00006124 - Active, not recruiting
recurrent bladder cancer
- Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
ClinicalTrials.gov Identifier: NCT00020878 - Active, not recruiting
Non-small cell lung cancer
- Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
ClinicalTrials.gov Identifier: NCT00014404 - Active, not recruiting
lip and oral cavity cancer; prevention of oral cancer
- Vinorelbine and Celecoxib in Treating Women With Relapsed or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00075673 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
Head and Neck Cancer; thorax and respiratory cancer
- Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
ClinicalTrials.gov Identifier: NCT00005094 - Active, not recruiting
prevention of colorectal cancer; Colon Cancer; Rectal Cancer
- Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
ClinicalTrials.gov Identifier: NCT00045591 - Active, not recruiting
recurrent breast cancer; stage IV breast cancer
- Celecoxib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Who Are Receiving Anticonvulsant Drugs and Undergoing Radiation Therapy
ClinicalTrials.gov Identifier: NCT00068770 - Active, not recruiting
adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00068653 - Active, not recruiting
recurrent non-small cell lung cancer
- Selenium and Celecoxib, Alone or in Combination, in Preventing Cancer in Patients With Esophageal Dysplasia
ClinicalTrials.gov Identifier: NCT00005885 - Active, not recruiting
prevention of esophageal cancer; Esophageal Cancer
- Celecoxib and/or Selenium in Treating Patients With Adenomatous Colorectal Polyps
ClinicalTrials.gov Identifier: NCT00078897 - Recruiting
Colon Cancer; Rectal Cancer
- Celecoxib Versus Naproxen for Prevention of Recurrent Ulcer Bleeding in Arthritis Patients
ClinicalTrials.gov Identifier: NCT00153660 - Recruiting
Arthritis; Cardiovascular Diseases; Cerebrovascular Disorders
- Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon
ClinicalTrials.gov Identifier: NCT00085163 - Active, not recruiting
adenocarcinoma of the colon; stage III colon cancer
- Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00068432 - Active, not recruiting
recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
- Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy
ClinicalTrials.gov Identifier: NCT00073970 - Active, not recruiting
recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate
- Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis
ClinicalTrials.gov Identifier: NCT00141102 - Recruiting
Osteoarthritis; Arthritis, Rheumatoid
- Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00047294 - Active, not recruiting
Mixed Gliomas; adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
- Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases
ClinicalTrials.gov Identifier: NCT00080782 - Active, not recruiting
recurrent prostate cancer; stage IV prostate cancer; bone metastases
- Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00064181 - Active, not recruiting
adenocarcinoma of the colon; adenocarcinoma of the rectum; stage IV colon cancer; Stage IV rectal cancer
- Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis.
ClinicalTrials.gov Identifier: NCT00033371 - Recruiting
Colon Cancer; Rectal Cancer
- Paclitaxel and Carboplatin With or Without Celecoxib Before Surgery in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062179 - Active, not recruiting
stage IIIA non-small cell lung cancer
- Celecoxib Treatment for Lung Cancer
ClinicalTrials.gov Identifier: NCT00108186 - Recruiting
Non-Small-Cell Lung Carcinoma
- Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma
ClinicalTrials.gov Identifier: NCT00047281 - Active, not recruiting
adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; adult brain tumor; adult glioblastoma; Mixed Gliomas
- Phase II Study on the Neoadjuvant Use of Chemotherapy and Celecoxib Therapy in Patients with Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00135018 - Recruiting
Breast Cancer
- Celecoxib and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00030407 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Etoposide and Celecoxib in Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00551005 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Cyclophosphamide and Celecoxib in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00551889 - Active, not recruiting
Unspecified Adult Solid Tumor, Protocol Specific
- Letrozole and Celecoxib in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00101062 - Active, not recruiting
stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer
- Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum
ClinicalTrials.gov Identifier: NCT00081224 - Active, not recruiting
adenocarcinoma of the rectum; stage II rectal cancer; stage III rectal cancer
- Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer
ClinicalTrials.gov Identifier: NCT00070057 - Active, not recruiting
stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
- Comparison of Two Combination Chemotherapy Regimens With or Without Celecoxib in Treating Women With Breast Cancer
ClinicalTrials.gov Identifier: NCT00087178 - Recruiting
stage I breast cancer; stage II breast cancer
- Celecoxib in Preventing Breast Cancer in Premenopausal Women
ClinicalTrials.gov Identifier: NCT00088972 - Recruiting
Breast Cancer; breast cancer in situ; lobular breast carcinoma in situ
- Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma Cancer
ClinicalTrials.gov Identifier: NCT00057980 - Active, not recruiting
advanced adult primary liver cancer; localized unresectable adult primary liver cancer; adult primary hepatocellular carcinoma
- Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus
ClinicalTrials.gov Identifier: NCT00066716 - Active, not recruiting
Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
- Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
ClinicalTrials.gov Identifier: NCT00320918 - Active, not recruiting
Cholangiocarcinoma
- Effects of Celecoxib After Percutaneous Coronary Intervention
ClinicalTrials.gov Identifier: NCT00292721 - Active, not recruiting
Coronary Arteriosclerosis
- Celecoxib in Treating Patients With Progressive Metastatic Differentiated Thyroid Cancer
ClinicalTrials.gov Identifier: NCT00061906 - Active, not recruiting
insular thyroid cancer; recurrent thyroid cancer; stage II follicular thyroid cancer; stage II papillary thyroid cancer; ...
- Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00030420 - Active, not recruiting
stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
- Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
ClinicalTrials.gov Identifier: NCT00081263 - Recruiting
Cervical Cancer; high-grade squamous intraepithelial lesion
- Phase II Study of Celecoxib and Concurrent Radiotherapy in Stage II-III NSCLC
ClinicalTrials.gov Identifier: NCT00181532 - Active, not recruiting
Non Small Cell Lung Carcinoma
- Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00070486 - Active, not recruiting
stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; Squamous Cell Lung Cancer; large cell lung cancer; ...
- Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00072553 - Active, not recruiting
Stage IV rectal cancer; stage IV colon cancer; adenocarcinoma of the colon; adenocarcinoma of the rectum; recurrent rectal cancer; ...
- Celecoxib in Preventing Skin Cancer
ClinicalTrials.gov Identifier: NCT00025051 - Recruiting
basal cell carcinoma of the skin; squamous cell carcinoma of the skin
- Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
ClinicalTrials.gov Identifier: NCT00055978 - Recruiting
Non-small cell lung cancer; stage I non-small cell lung cancer
- Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00104767 - Active, not recruiting
stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
- Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00046839 - Active, not recruiting
stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
- Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00072072 - Active, not recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00093678 - Not yet recruiting
Cachexia; Cancer; Pain
- Erlotinib and Celecoxib in Treating Patients With Stage IIIB or Stage IV Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00062101 - Active, not recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Celecoxib and Gefitinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00088959 - Active, not recruiting
recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
- Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00112502 - Recruiting
adult giant cell glioblastoma; adult gliosarcoma; adult glioblastoma
- Celecoxib as a Post-Tonsillectomy Pain Medication
ClinicalTrials.gov Identifier: NCT00583453 - Recruiting
Tonsillitis
- Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
ClinicalTrials.gov Identifier: NCT00258232 - Active, not recruiting
Colorectal Cancer
- Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00336960 - Active, not recruiting
Colorectal Cancer
- Celecoxib (Celebrex) in the Management of Acute Renal Colic
ClinicalTrials.gov Identifier: NCT00304317 - Recruiting
Ureteral Calculi
- Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00176813 - Active, not recruiting
Pancreatic Cancer
- Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00177853 - Active, not recruiting
Pancreatic Cancer
- Efficacy of Celecoxib Vs Placebo to Prevent Pain in a Paced Walk
ClinicalTrials.gov Identifier: NCT00194090 - Recruiting
Knee Osteoarthritis
- Celecoxib and Erlotinib in Treating Patients With Liver Cancer
ClinicalTrials.gov Identifier: NCT00293436 - Active, not recruiting
Liver Cancer
- CPT-11 and Celecoxib With Radiation Therapy for Patients With Unresectable NSCLC
ClinicalTrials.gov Identifier: NCT00346801 - Recruiting
Lung Cancer
- Combination Chemotherapy, Celecoxib, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00089024 - Recruiting
adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer
- Celecoxib in Treating Patients With Familial Adenomatous Polyposis
ClinicalTrials.gov Identifier: NCT00258219 - Recruiting
Colorectal Cancer; Precancerous/Nonmalignant Condition
- PRECISION : Prospective Randomized Evaluation of Celecoxib Integrated Safety vs Ibuprofen Or Naproxen
ClinicalTrials.gov Identifier: NCT00346216 - Recruiting
Osteoarthritis; Arthritis, Rheumatoid
- Irinotecan, Cisplatin, and Radiation Therapy With or Without Celecoxib in Treating Patients With Stage II, Stage III, or Stage IV Esophageal Cancer
ClinicalTrials.gov Identifier: NCT00520091 - Active, not recruiting
Esophageal Cancer
- Cetuximab and Celecoxib in Treating Patients With Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery
ClinicalTrials.gov Identifier: NCT00466505 - Active, not recruiting
Colorectal Cancer
- Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial
ClinicalTrials.gov Identifier: NCT00520338 - Recruiting
Postoperative Pain; Thyroidectomy; Cyclooxygenase 2 Inhibitors
- Safety/Efficacy of Camptosar, Avastin, & 5-FU/LV 2-Schedules w/ Celebrex/Placebo as Colorectal Cancer Initial Treatment
ClinicalTrials.gov Identifier: NCT00101686 - Active, not recruiting
Colorectal Cancer; Metastases
- Open Label Comparative Study on Celecoxib Efficacy and Safety vs Non-Selective NSAID in Acute Pain Due to Ankle Sprain
ClinicalTrials.gov Identifier: NCT00446797 - Recruiting
Sprains and Strains
- Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00581971 - Recruiting
Cancer
- Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma
ClinicalTrials.gov Identifier: NCT00099047 - Not yet recruiting
Multiple Myeloma; monoclonal gammopathy of undetermined significance
- GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (Nsaids) I
ClinicalTrials.gov Identifier: NCT00373685 - Recruiting
Osteoarthritis
- Celebrex - Cervix
ClinicalTrials.gov Identifier: NCT00152828 - Active, not recruiting
Cervix Neoplasms
- Celecoxib in Treating Patients With High-Grade Squamous Intraepithelial Lesions of the Cervix
ClinicalTrials.gov Identifier: NCT00072540 - Not yet recruiting
stage 0 cervical cancer; high-grade squamous intraepithelial lesion
- Arthroplasty Inflammation Prophylaxis With Celecoxib
ClinicalTrials.gov Identifier: NCT00533247 - Not yet recruiting
Postoperative Pain
- Celecoxib and Docetaxel or Pemetrexed in Treating Patients With Advanced Recurrent Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00520845 - Recruiting
Lung Cancer
- Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00201773 - Recruiting
Breast Cancer
- A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer
ClinicalTrials.gov Identifier: NCT00215345 - Recruiting
Prostate Cancer
- 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
ClinicalTrials.gov Identifier: NCT00504660 - Recruiting
Anaplastic Glioma; Glioblastoma Multiforme; Brain Cancer
- A Study Of CP-195543 And Celecoxib Dual Therapy In Subjects With Rheumatoid Arthritis
ClinicalTrials.gov Identifier: NCT00424294 - Recruiting
Arthritis, Rheumatoid
- Androgen Suppression Alone or Combined With Zoledronate, Docetaxel, Prednisolone, and/or Celecoxib in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
ClinicalTrials.gov Identifier: NCT00268476 - Recruiting
Prostate Cancer
- Celecoxib in Preventing Colorectal Cancer in Young Patients With a Genetic Predisposition for Familial Adenomatous Polyposis
ClinicalTrials.gov Identifier: NCT00393016 - Recruiting
Colorectal Cancer; Precancerous/Nonmalignant Condition
- Exemestane + Celecoxib vs Exemestane + Placebo in Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00525096 - Active, not recruiting
Metastatic Breast Cancer
- A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
ClinicalTrials.gov Identifier: NCT00218205 - Recruiting
Prostate Cancer
- Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer
ClinicalTrials.gov Identifier: NCT00250835 - Recruiting
Rectal Cancer
- Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Treating Young Patients With Relapsed or Progressive Cancer
ClinicalTrials.gov Identifier: NCT00357500 - Recruiting
Brain and Central Nervous System Tumors; Leukemia; Lymphoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific
- A Study Of Nasopharyngeal Carcinoma (NPC) Treated With Celecoxib And ZD1839
ClinicalTrials.gov Identifier: NCT00212108 - Recruiting
Nasopharyngeal Carcinoma
- Celecoxib and/or EKB-569 in Preventing Oral Cancer in Patients With Oral Leukoplakia
ClinicalTrials.gov Identifier: NCT00088842 - Not yet recruiting
lip and oral cavity cancer; Salivary Gland Cancer; Precancerous Condition
- Effects of Celecoxib On Restenosis After Coronary Intervention and Evolution of Atherosclerosis Trial
ClinicalTrials.gov Identifier: NCT00500279 - Recruiting
Angioplasty, Transluminal, Percutaneous Coronary; Coronary Restenosis
- Rectal Aberrant Crypt Foci and Other Intermediate Biomarkers for Sporadic Colorectal Neoplasia: Cross-Sectional Prevalence and Modulation by Celecoxib
ClinicalTrials.gov Identifier: NCT00056615 - Completed
Adenoma; Colorectal Neoplasms
- The Standard Care Versus Celecoxib Outcome Trial
ClinicalTrials.gov Identifier: NCT00447759 - Not yet recruiting
Osteoarthritis; Rheumatoid Arthritis
- Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP)
ClinicalTrials.gov Identifier: NCT00141193 - Active, not recruiting
Colorectal Sporadic Adenomatous Polyps
- Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
ClinicalTrials.gov Identifier: NCT00450736 - Recruiting
Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
- Celecoxib or Observation After Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00274898 - Recruiting
Lung Cancer
Resources
- Celebrex (Drug Digest)
- Celebrex Consumer Information (U.S. Food and Drug Administration)
email this page
print this page
bookmark this page
feedback on this page
